PharmaCyte Biotech, Inc. (PMCB)
0.3422
0.00 (0.00%)
USD |
NASDAQ |
Oct 20, 16:00
0.3411
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech Market Cap : 3.674M for Oct. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 20, 2026 | 3.674M |
| October 19, 2026 | 3.672M |
| October 16, 2026 | 3.652M |
| October 15, 2026 | 3.837M |
| October 14, 2026 | 3.741M |
| October 13, 2026 | 3.821M |
| October 12, 2026 | 3.920M |
| October 09, 2026 | 4.342M |
| October 08, 2026 | 4.266M |
| October 07, 2026 | 4.354M |
| October 06, 2026 | 4.535M |
| October 05, 2026 | 4.188M |
| October 02, 2026 | 4.295M |
| October 01, 2026 | 4.336M |
| September 30, 2026 | 4.408M |
| September 29, 2026 | 4.498M |
| September 28, 2026 | 4.508M |
| September 25, 2026 | 4.734M |
| September 24, 2026 | 4.900M |
| September 23, 2026 | 4.600M |
| September 22, 2026 | 4.922M |
| September 21, 2026 | 4.840M |
| September 18, 2026 | 4.935M |
| September 17, 2026 | 4.552M |
| September 16, 2026 | 4.468M |
| Date | Value |
|---|---|
| September 15, 2026 | 4.104M |
| September 14, 2026 | 4.208M |
| September 11, 2026 | 4.833M |
| September 10, 2026 | 4.748M |
| September 09, 2026 | 5.103M |
| September 08, 2026 | 5.250M |
| September 04, 2026 | 5.223M |
| September 03, 2026 | 5.274M |
| September 02, 2026 | 5.161M |
| September 01, 2026 | 5.24M |
| August 31, 2026 | 5.378M |
| August 28, 2026 | 5.529M |
| August 27, 2026 | 5.799M |
| August 26, 2026 | 5.803M |
| August 25, 2026 | 5.793M |
| August 24, 2026 | 5.636M |
| August 21, 2026 | 5.722M |
| August 20, 2026 | 5.521M |
| August 19, 2026 | 5.716M |
| August 18, 2026 | 5.626M |
| August 17, 2026 | 5.821M |
| August 14, 2026 | 5.915M |
| August 13, 2026 | 5.905M |
| August 12, 2026 | 5.877M |
| August 11, 2026 | 5.905M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 273.59M |
| Amgen, Inc. | 237.29B |
| Anika Therapeutics, Inc. | 273.55M |
| BioCryst Pharmaceuticals, Inc. | 2.027B |
| Imunon, Inc. | 4.689M |
Market Cap Related Metrics
| PEG Ratio | -0.0003 |
| Price to Book Value | 0.1335 |
| Price | 0.3422 |
| Earnings Yield | -701.2% |
| PEGY Ratio | -0.0003 |